ClinicalTrials.Veeva

Menu

Multidisciplinary Care Program to Secure MEdication Therapy for HematoLOgy Patients Receiving Injectable Anticancer Drugs (Melodia)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Chemotherapy Effect
R-CHOP Chemotherapy
G-CHOP Chemotherapy

Treatments

Other: Literacy questionnaire
Other: Assessment of patient satisfaction regarding tele-consultation
Other: Assessment of patient satisfaction on pharmaceutical follow-up
Other: Assessment of patient knowledge on chemotherapy side effects and support medications
Other: Collection of socio-demographic characteristics

Study type

Observational

Funder types

Other

Identifiers

NCT05350930
69HCL22_0292

Details and patient eligibility

About

Several experiences of multidisciplinary care pathways associating oncologists, pharmacists and nurses have been reported for cancer patients, with positive results on medication management safety, reduction of Drug-Related Problems (DRPs), and re-hospitalizations.

This study aims to evaluate the impact of a multidisciplinary city-hospital follow-up program on medication management safety in haematological oncology patients receiving intravenous chemotherapy in onco-haematology. Additional aspects will be evaluated, such as the impact of the follow-up on the city-hospital link, satisfaction of patients and professionals involved in the follow-up and the use of telecare

Enrollment

38 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Adult patients aged 18 years or older With hematological malignancy at any stage Initiating R-CHOP or G-CHOP chemotherapy Who do not object to participation in the study and use of collected data

Exclusion criteria

  • Patients already enrolled in a clinical trial evaluating any drug product

  • Patients living in an institution

  • Patients protected by law

    • Adults subject to a legal protection measure (curatorship, guardianship) (article L1121-8 of the CSP)
    • Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care and persons admitted to a health or social establishment (article L1121-6 of the CSP)

Trial design

38 participants in 1 patient group

R-CHOP or G-CHOP chemotherapy
Description:
Patients with hematological malignancies receiving R-CHOP or G-CHOP chemotherapy
Treatment:
Other: Collection of socio-demographic characteristics
Other: Assessment of patient knowledge on chemotherapy side effects and support medications
Other: Assessment of patient satisfaction on pharmaceutical follow-up
Other: Assessment of patient satisfaction regarding tele-consultation
Other: Literacy questionnaire

Trial contacts and locations

1

Loading...

Central trial contact

Catherine RIOUFOL, Pr.; amandine baudouin, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems